Analyst Ratings for BioAtla Inc. (BCAB)
BCAB Rating Summary
BCAB Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.00 (+9.3%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
Avg. $ Target:
$4.00 (+9.3%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/13/2026 | Rodman & Renshaw | Michael King Jr. | New Coverage | Buy (N/A) |
4.00 (N/A) |
0.31 (3.66) |
1080.65% | Details |
| 8/13/2025 | Citizens » Updated 9/9/2025 |
Reni Benjamin | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
0.36 (3.66) |
916.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
